Good_老虎社区_美港股上老虎

Xkuanx
2021-11-05

Good

Illumina Surpasses Q3 Earnings and Revenue Estimates

Illumina (ILMN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Est

Illumina Surpasses Q3 Earnings and Revenue Estimates

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":846649800,"tweetId":"846649800","gmtCreate":1636080685205,"gmtModify":1636081030408,"author":{"id":3572907325602131,"idStr":"3572907325602131","authorId":3572907325602131,"authorIdStr":"3572907325602131","name":"Xkuanx","avatar":"https://static.tigerbbs.com/e90936aad3336fa7f5cc5bc70cbab1fc","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":55,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good</p></body></html>","htmlText":"<html><head></head><body><p>Good</p></body></html>","text":"Good","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/846649800","repostId":2181594718,"repostType":4,"repost":{"id":"2181594718","pubTimestamp":1636069269,"share":"https://www.laohu8.com/m/news/2181594718?lang=&edition=full","pubTime":"2021-11-05 07:41","market":"us","language":"en","title":"Illumina Surpasses Q3 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2181594718","media":"Zacks","summary":"Illumina (ILMN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Est","content":"<p><a href=\"https://laohu8.com/S/ILMN\">Illumina</a> (ILMN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items.</p>\n<p>This quarterly report represents an earnings surprise of 16.94%. A quarter ago, it was expected that this genetic testing tools company would post earnings of $1.36 per share when it actually produced earnings of $1.87, delivering a surprise of 37.50%.</p>\n<p>Over the last four quarters, the company has surpassed consensus EPS estimates four times.</p>\n<p>Illumina, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.11 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 6.63%. This compares to year-ago revenues of $794 million. The company has topped consensus revenue estimates four times over the last four quarters.</p>\n<p>The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.</p>\n<p>Illumina shares have added about 13.4% since the beginning of the year versus the S&amp;P 500's gain of 24.1%.</p>\n<p>Illumina&nbsp;shares&nbsp;rose&nbsp;2.65%&nbsp;in&nbsp;after-hours&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/feb109d6922b92b37bdd39e20b581f1f\" tg-width=\"884\" tg-height=\"598\" width=\"100%\" height=\"auto\"></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Illumina Surpasses Q3 Earnings and Revenue Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIllumina Surpasses Q3 Earnings and Revenue Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 07:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/illumina-ilmn-surpasses-q3-earnings-214509383.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Illumina (ILMN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.02 per share a year ago. These figures are...</p>\n\n<a href=\"https://finance.yahoo.com/news/illumina-ilmn-surpasses-q3-earnings-214509383.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ILMN":"Illumina"},"source_url":"https://finance.yahoo.com/news/illumina-ilmn-surpasses-q3-earnings-214509383.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2181594718","content_text":"Illumina (ILMN) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items.\nThis quarterly report represents an earnings surprise of 16.94%. A quarter ago, it was expected that this genetic testing tools company would post earnings of $1.36 per share when it actually produced earnings of $1.87, delivering a surprise of 37.50%.\nOver the last four quarters, the company has surpassed consensus EPS estimates four times.\nIllumina, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $1.11 billion for the quarter ended September 2021, surpassing the Zacks Consensus Estimate by 6.63%. This compares to year-ago revenues of $794 million. The company has topped consensus revenue estimates four times over the last four quarters.\nThe sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.\nIllumina shares have added about 13.4% since the beginning of the year versus the S&P 500's gain of 24.1%.\nIllumina shares rose 2.65% in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1068,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}